Online Database of Chemicals from Around the World

3-[5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyloxazolidin-2-one
[CAS# 439080-96-3]

List of Suppliers
Tianjin Chempharmatech Co., Ltd. China Inquire  
+86 (22) 6621-1079
wuzhanyuan@chempharmatech.com
Chemical manufacturer since 2012
chemBlink standard supplier since 2016
Complete supplier list of 3-[5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyloxazolidin-2-one
Identification
Name 3-[5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyloxazolidin-2-one
Molecular Structure CAS # 439080-96-3, 3-[5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyloxazolidin-2-one
Molecular Formula C20H20FNO4
Molecular Weight 357.38
CAS Registry Number 439080-96-3
Properties
Solubility Practically insoluble (0.024 g/L) (25 ºC), Calc.*
Density 1.297±0.06 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2016 ACD/Labs)
Market Analysis Reports
List of Reports Available for 3-[5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyloxazolidin-2-one
Related Products
(S)-3-(3-Fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one  (R)-3-(3-Fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one  (3S,4R)-4-(4-Fluorophenyl)-3-(hydroxymethyl)-1-piperidinecarboxylic acid phenylmethyl ester  (3S,4R)-4-(4-Fluorophenyl)-3-(hydroxymethyl)-1-piperidinecarboxylic acid tert-butyl ester  (3R,5S,6E)-7-[4-(4-Fluorophenyl)-2-[[(2-hydroxy-2-methylpropyl)sulfonyl]methylamino]-6-(1-methylethyl)-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid calcium salt  (3R,5S,6E)-7-[4-(4-Fluorophenyl)-2-[[(2-hydroxy-2-methylpropyl)sulfonyl]methylamino]-6-(1-methylethyl)-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid sodium salt (1:1)  (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-2-oxazolidinone  (4S)-3-[(5R)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone  (4R)-3-[(5R)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone  (5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-5-phenyl-2-pyrrolidinone  (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one  3-[(5S)-(4-Fluorophenyl)-5-hydroxypentanoyl]-(4R)-phenyl-1,3-oxazolidin-2-one  (4R,6R)-6-[2-[2-(4-Fluorophenyl)-4-[[(4-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid tert-butyl ester  1-O-[(3R,5R)-7-{2-(4-Fluorophenyl)-4-[(Z)-hydroxy(phenylimino)methyl]-5-isopropyl-3-phenyl-1H-pyrrol-1-yl}-3,5-dihydroxyheptanoyl]-β-D-glucopyranuronic acid  (4-Fluorophenyl)(4-hydroxy-1-piperidinyl)methanone  (2-Fluorophenyl)(4-hydroxy-1-piperidinyl)methanone  (2-Fluorophenyl)(3-hydroxy-1-piperidinyl)methanone  1-(4-Fluorophenyl)-4-(7-hydroxyspiro[benzofuran-3(2H),4'-piperidin]-1'-yl)-1-butanone hydrochloride  4-(4-Fluorophenyl)-7-[[[5-[(1S)-1-hydroxy-1-(trifluoromethyl)propyl]-1,3,4-oxadiazol-2-yl]amino]methyl]-2H-1-benzopyran-2-one  2-(2-Fluorophenyl)-1H-imidazole-5-methanol